Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Suzanne Delfortrie"'
Autor:
Sébastien Pinte, Chantal Havet, Gaëlle Villain, Suzanne Delfortrie, Fabrice Soncin, Virginie Mattot
Publikováno v:
Oncology Reports
Oncology Reports, Spandidos Publications, 2021, 47 (1), ⟨10.3892/OR.2021.8219⟩
Oncology Reports, Spandidos Publications, 2021, 47 (1), pp.8. ⟨10.3892/or.2021.8219⟩
Oncology Reports, 2021, 47 (1), pp.8. ⟨10.3892/or.2021.8219⟩
Oncology Reports, Spandidos Publications, 2021, 47 (1), ⟨10.3892/OR.2021.8219⟩
Oncology Reports, Spandidos Publications, 2021, 47 (1), pp.8. ⟨10.3892/or.2021.8219⟩
Oncology Reports, 2021, 47 (1), pp.8. ⟨10.3892/or.2021.8219⟩
International audience; The tumor blood vessel endothelium forms a barrier that must be crossed by circulating immune cells in order for them to reach and kill cancer cells. Epidermal growth factor‑like domain 7 (Egfl7) represses this immune infilt
Autor:
Géraldine Lauridant-Philippin, Bertrand Caetano, Virginie Mattot, Gaëlle Villain, Christelle Faveeuw, Jacques Bonneterre, Sébastien Pinte, Fabrice Soncin, Chantal Samson, Suzanne Delfortrie, Marie-Christine Baranzelli, François Trottein
Publikováno v:
Cancer Research. 71:7176-7186
Downregulating the leukocyte adhesion molecules expressed by endothelial cells that line tumor blood vessels can limit the entry of immune effector cells into the tumor mass, thereby contributing to tumoral immune escape. Egfl7 (also known as VE-stat
Publikováno v:
Oncology Reports.
Bortezomib and other proteasome inhibitors have demonstrated an interesting antitumor activity against glioma cell lines. The present study aimed to evaluate the cytotoxic potential of bortezomib in vivo on two human malignant glioma xenografts using